Marshall Wace LLP Has $88.14 Million Position in The Clorox Company (NYSE:CLX)

Marshall Wace LLP grew its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 549.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 542,726 shares of the company's stock after acquiring an additional 459,203 shares during the period. Marshall Wace LLP owned about 0.44% of Clorox worth $88,144,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Brooklyn Investment Group raised its position in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Redwood Park Advisors LLC bought a new position in Clorox during the 4th quarter valued at $26,000. Millstone Evans Group LLC acquired a new position in Clorox during the 4th quarter worth $31,000. Asset Planning Inc bought a new stake in shares of Clorox in the 4th quarter worth about $32,000. Finally, Aster Capital Management DIFC Ltd acquired a new stake in shares of Clorox in the 4th quarter valued at about $33,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on CLX shares. Evercore ISI lifted their price target on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. UBS Group lowered their target price on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research note on Thursday. DA Davidson decreased their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Finally, Barclays cut their target price on shares of Clorox from $139.00 to $134.00 and set an "underweight" rating on the stock in a report on Friday, April 11th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat, Clorox currently has a consensus rating of "Hold" and a consensus target price of $153.83.

Clorox Stock Performance

CLX stock traded up $2.80 during trading on Friday, reaching $139.60. 948,624 shares of the company's stock were exchanged, compared to its average volume of 1,304,252. The firm has a market cap of $17.20 billion, a PE ratio of 38.14, a P/E/G ratio of 2.62 and a beta of 0.61. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The company's fifty day moving average price is $146.57 and its 200-day moving average price is $156.40.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the firm earned $2.16 earnings per share. On average, research analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.50%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.